DiaCarta
DiaCarta Radiation Toxicity Liquid Biopsy Test Deployed in Florida Cancer Treatment Response Project
DiaCarta's RadTox cell-free DNA test will be used throughout Florida as part of a $1 million research project financed by the Florida Cancer Innovation Fund.
DiaCarta, OncoAssure Collaborate on Prostate Cancer LDT Launch
The firms said that DiaCarta's laboratory facilities in California will be used to validate the prostate cancer assay for a commercial launch.
DiaCarta to Explore XNA Clamp Tech for Low-Frequency Mutations Under NIH Collaboration
Working under a two-year cooperative R&D agreement, the firm will explore its platform for cancer and rare disease mutation detection and in situ cancer cell analyses.